Shenyang Sunshine Pharmaceutical Co., Ltd.
Clinical trials sponsored by Shenyang Sunshine Pharmaceutical Co., Ltd., explained in plain language.
-
New bladder cancer drug combo shows promise in early trial
Disease control Not yet recruitingThis study tests a new drug called SPGL008, given alone or with a standard therapy (BCG), for people with a type of bladder cancer that hasn't spread into the muscle wall. The main goals are to find the safest dose and see if the drug helps control the cancer. About 120 adults wh…
Phase: PHASE1, PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated May 17, 2026 08:32 UTC
-
New combo therapy targets tough gut cancers in major trial
Disease control Not yet recruitingThis study tests a new drug called SSGJ-706 combined with standard treatments for people with advanced stomach, colon, pancreatic, or esophageal cancers that cannot be removed by surgery. The goal is to see if the combination is safe and helps shrink or control tumors. About 300 …
Phase: PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New drug SSS67: first human tests begin in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a single dose of an experimental drug, SSS67, in 52 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo by IV, and researchers monitor for side effects, drug levels, and immune responses…
Phase: PHASE1 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC